Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?

The article compares two major cannabis companies navigating industry challenges. Canopy Growth focuses on premium Canadian cannabis and European medical sales but faces internal control weaknesses and significant losses. Tilray Brands has diversified into beverages and international markets, posting record Q1 revenue of $257M with improving margins. The author recommends Tilray as the better choice due to its larger scale, diversified revenue streams, and clearer path to profitability, though both stocks remain risky investments in a volatile industry.

10/15/2026, 5:54 PM • The Motley Fool

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

SweetWater Brewing, a craft brewery brand by Tilray Brands, launched a concert sweepstakes giving fans 21+ the chance to win tickets to 2026-2027 AEG concerts at select Georgia venues including Georgia Theatre, The Eastern, Variety Playhouse, and Terminal West. Two winners will be selected with prizes valued at approximately $1,200 each, including concert tickets and travel gift cards. The sweepstakes runs through December 31, 2026.

10/15/2026, 7:00 AM • GlobeNewswire

3 Huge Red Flags From Tilray's Q1 Earnings Report

Tilray Brands reported Q1 fiscal 2027 results with concerning fundamentals despite revenue growth. The company's cash burn spiked to $16.5 million (up from $1.3 million year-over-year), core cannabis revenue declined 13%, and operating expenses surged 83%. While top-line growth was driven by acquisitions like BrewDog, organic cannabis business weakness and ballooning costs suggest the stock faces continued headwinds.

10/12/2026, 2:25 PM • The Motley Fool

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

Canopy Growth and Tilray Brands represent diverging strategies in the cannabis industry. Canopy pursues a lean, brand-focused model with emphasis on U.S. expansion, while Tilray has diversified into craft beverages and wellness products. Both companies reported significant net losses in FY 2026 despite revenue growth, with Tilray showing better financial metrics (higher revenue, lower debt-to-equity ratio, higher gross margin) but greater business complexity. The article suggests Tilray may appeal to diversification-focused investors, while Canopy attracts those betting on pure cannabis growth, though both carry substantial risks.

10/10/2026, 5:18 PM • The Motley Fool

Tilray Brands: Is the Stock a Buy at Less Than $4?

Tilray Brands stock has crashed 60% this year and trades below $4, down 84% from its 52-week high. Despite record revenue of $915 million, the company posted a net loss of $105 million and burned $69 million in cash. The analyst recommends avoiding the stock due to poor growth prospects, a highly competitive Canadian market, and a questionable pivot to beverages that doesn't address fundamental business challenges.

10/06/2026, 9:15 AM • The Motley Fool

Tilray Brands Has Lost More Than Half of Its Value in 2026, but Here's the Bullish Case for Taking a Chance on This Highly Risky Stock

Tilray Brands has lost over 50% of its value in 2026 and is down 95% over five years, making it a highly risky investment. However, the bullish case centers on potential U.S. marijuana legalization, which could trigger significant stock appreciation even before full legalization occurs. The company has diversified into beverages and alcohol to position itself for future U.S. market entry. While the stock could surge on legalization discussions similar to Canada's 2018 experience, investors should be aware of substantial risks and uncertainty.

09/15/2026, 10:39 AM • The Motley Fool

Should You Buy Canopy Growth Stock on the Rebound?

Canopy Growth showed strong Q1 fiscal 2027 results with 13% revenue growth across all business divisions, improved gross margins, and significantly reduced losses. However, the company remains a penny stock with over 400% share dilution in three years. While the business turnaround is promising, the article recommends most investors monitor rather than buy, citing the sector's history of underperformance and the need to see sustained improvement before investing.

09/05/2026, 7:15 AM • The Motley Fool

By Popular Demand: Tilray Beverages Makes Popsicle Hard Firecracker a Permanent Flavor

Tilray Brands and The Magnum Ice Cream Company announced that Popsicle Hard Firecracker, a limited-edition nostalgic red-white-and-blue flavored hard beverage, will transition to a permanent year-round offering following overwhelming consumer demand. The flavor joins existing year-round offerings including Hard Cherry, Hard Grape, and Hard Orange in the Popsicle Hard portfolio.

09/02/2026, 7:00 AM • GlobeNewswire

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

The cannabis sector is undergoing consolidation as weaker players exit and stronger companies acquire competitors. Curaleaf has made an unsolicited $4 per share bid for Aurora Cannabis. The article identifies Canopy Growth and Tilray Brands as the biggest potential winners in this consolidation trend, with Canopy benefiting from its balance sheet reset and Tilray diversifying beyond marijuana into alcohol and consumer brands.

08/21/2026, 8:15 AM • The Motley Fool

The Surprising Part of Tilray's Business That Drove Most of Its Growth Last Year

Tilray Brands reported 11% revenue growth to $915.5 million in fiscal 2026, with its distribution business driving the majority of growth at 21%, significantly outpacing beverage (6%) and cannabis segments. However, the company remains unprofitable with an $63 million operating loss, raising concerns about its viability as an investment despite recent stock gains.

08/03/2026, 12:17 PM • The Motley Fool

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

BrewDog and Tilray Brands are launching a £1 million bar tab promotion at participating BrewDog pubs across England, Scotland, and Ireland from July 20 through September 30, 2026. The promotion offers fans two free pints per person via the BrewDog Treats loyalty platform, available on a first-come, first-served basis. The initiative aims to bring football supporters together for watch parties and celebrations throughout the tournament season.

07/17/2026, 7:00 AM • GlobeNewswire

President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray

President Trump's executive order to reschedule medical marijuana from Schedule I to Schedule III provides limited benefits to major cannabis companies. While the rescheduling eliminates IRS Section 280E tax restrictions for medical marijuana businesses, it only applies to medical products, not the larger recreational market. Canopy Growth, Tilray, and Green Thumb Industries face minimal direct impact due to their business structures and market focus, though the change creates new regulatory compliance burdens.

07/17/2026, 5:30 AM • The Motley Fool

Breckenridge Distillery Launches Breck Vodka Seltzer, a Crisp New Ready-to-Drink Line Born in the Rockies

Breckenridge Distillery, a subsidiary of Tilray Brands, announced the launch of Breck Vodka Seltzer, a new ready-to-drink product line available in four flavors (lime, grapefruit, peach, and tropical) at 5% ABV. The product is currently available in Colorado retailers with national expansion planned for Fall 2026, priced at $11-13.99 for 4-packs and $18.99-19.99 for 8-pack variety formats.

07/09/2026, 1:00 PM • GlobeNewswire

Should You Buy Tilray Stock Before July 15?

On July 15, the DEA will conclude its hearing on rescheduling cannabis from Schedule I to Schedule III. While Tilray doesn't directly operate U.S. cannabis businesses and won't immediately benefit from tax relief, the company is well-positioned for long-term cannabis reform with its diversified international medical cannabis business, craft beverages, and wellness products. With $630M in revenue and $265M in cash, investors should focus on multi-year reform prospects rather than short-term headline reactions.

07/07/2026, 4:15 PM • The Motley Fool

Is Tilray a Textbook Value Trap -- or the Most Undervalued Cannabis Stock on the Market?

Tilray Brands has lost over 90% of its value in five years and remains unprofitable despite diversifying into craft brewing, hemp wellness, and pharmaceuticals. While recent U.S. cannabis reclassification to Schedule III could create medical research opportunities, the company faces significant headwinds including weak financial results, stringent regulations, and intense competition. The analyst recommends Green Thumb Industries as a better cannabis investment alternative.

07/02/2026, 8:30 PM • The Motley Fool